The American Brain Tumor Association’s partner, The Sontag Foundation, has established the COVID-19 Emergency Patient Assistance Fund, which provides financial support to patients with a brain tumor diagnosis or their caregivers, who have been impacted by COVID-19.
Patients who meet certain criteria will be eligible to receive a grant of $500. This grant can help patients with their basic daily needs, including food, rent or mortgage, utility bills, car payments and other transportation expenses, childcare, and temporary lodging for medical appointments. Grants will be provided on a first-come, first-served basis until funds are expended.
“We are grateful to The Sontag Foundation for taking swift action to help the brain tumor community navigate the unexpected challenges brought on by the pandemic,” said Ralph DeVitto, president and CEO of the American Brain Tumor Association.”
“Before COVID-19 most families impacted by a brain tumor already were under financial stress from medical bills and other costs associated with the disease. With the disruption to employment and other changes brought on by this pandemic the financial burden for them has become overwhelming,” said Rick Sontag, founder and president of The Sontag Foundation. “We are grateful to have the ability to establish an emergency fund like this.”
Note: the Sontag Foundation Covid-19 Emergency Patient Assistance Fund is closed at this time.
About Meet Hope Head On
Because of the generous support from people like you, the ABTA has given over $35 million for brain tumor research. The ABTA’s campaign, “Meet Hope Head On,” created for our 50th anniversary, is focused on raising $50 million, in part to fund critical brain tumor research. This campaign is vital for continuing the kind of work that led to the recent FDA approval of vorasidenib, a breakthrough treatment for low-grade glioma.